Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

Lines died from drug withdrawal in the Las Colinas women’s jail in May, a day after her arrest. Dean, who suffered from ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

The deal brings Dark Blue's preclinical oncology products, including an MLLT1/3-targeted agent for leukemias, into Amgen's portfolio.

The new Phase III study will test calderasib in a chemo-free regimen for G12C-mutated patients regardless of PD-L1 status.

The trial met its primary endpoint with a hazard ratio of 0.75, indicating a significant reduction in disease progression ...

The OSU/A&M Board of Regents voted to give AT&T Oklahoma a utility easement nearby the Stillwater stadium to build a new line and improve phone coverage.

Rehoboth Beach purchased 30 Flock cameras, but only four have license plate reading technology. Those four cameras cost the ...